|
|
|
Insider
Information: |
Hillan Kenneth |
Relationship: |
Chief Therapeutics Off... |
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
589,812 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$139,323 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
589,812 |
|
|
Total
Value |
$139,323 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-47.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Achaogen Inc |
AKAO |
See Remarks, Director |
2018-06-28 |
293,336 |
2015-03-11 |
0 |
Premium* |
|
Relypsa Inc |
RLYP |
Director |
2016-09-01 |
0 |
2015-06-04 |
0 |
Premium* |
|
Sangamo Biosciences Inc |
SGMO |
|
2024-06-04 |
74,600 |
2020-09-09 |
0 |
Premium* |
|
23andMe Holding Co. |
ME |
Chief Therapeutics Off... |
2023-06-05 |
221,876 |
2022-02-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ME |
23andMe Holding Co. |
Chief Therapeutics Officer |
|
2022-11-20 |
4 |
D |
$2.99 |
$13,838 |
D/D |
(4,628) |
197,162 |
0 |
- |
|
ME |
23andMe Holding Co. |
Chief Therapeutics Officer |
|
2023-02-20 |
4 |
D |
$2.87 |
$15,662 |
D/D |
(5,457) |
191,705 |
0 |
- |
|
ME |
23andMe Holding Co. |
Chief Therapeutics Officer |
|
2023-05-20 |
4 |
D |
$1.94 |
$8,978 |
D/D |
(4,628) |
192,842 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
Director |
|
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,900 |
49,600 |
0 |
- |
|
ME |
23andMe Holding Co. |
Chief Therapeutics Officer |
|
2023-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
44,381 |
237,223 |
0 |
- |
|
ME |
23andMe Holding Co. |
Chief Therapeutics Officer |
|
2023-06-05 |
4 |
D |
$2.08 |
$31,922 |
D/D |
(15,347) |
221,876 |
0 |
- |
|
SGMO |
Sangamo Biosciences Inc |
|
|
2024-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
74,600 |
0 |
- |
|
32 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|